School of Medicine
Showing 1-12 of 12 Results
-
Carla Abdelnour
Postdoctoral Scholar, Neurology and Neurological Sciences
BioOriginally from Caracas, Venezuela, Dr. Carla Abdelnour received her medical degree at the Central University of Venezuela, and then completed her neurology residency training at the University Hospital Príncipe de Asturias in Madrid, Spain. She conducted her doctorate in Medicine at the Autonomous University of Barcelona working with Drs. Dag Aarsland, Javier Pagonabarraga and Jaime Kulisevsky. Her thesis focused on the influence of Alzheimer´s disease copathology in atrophy patterns, longitudinal cognitive decline, and heterogeneity of patients with dementia with Lewy bodies.
Carla´s main interest is the study of neurodegenerative diseases, especially Lewy body disease. Her plan is to investigate the impact of different comorbidities in the clinical presentation, cognitive profile, and disease progression of Lewy body disease. Additionally, she wants to study the biological underpinnings of prodromal Lewy body disease to identify potential biomarkers for diagnosis and prognosis. -
Gregory W. Albers, MD
Coyote Foundation Professor and Professor, by courtesy, of Neurosurgery
On Partial Leave from 04/01/2022 To 11/30/2022Current Research and Scholarly InterestsOur group's research focus is the acute treatment and prevention of cerebrovascular disorders. Our primary interest is the use of advanced imaging techniques to expand the treatment window for ischemic stroke. We are also conducting clinical studies of both neuroprotective and thrombolytic strategies for the treatment of acute stroke and investigating new antithrombotic strategies for stroke prevention.
-
Katrin Andreasson
Professor of Neurology
Current Research and Scholarly InterestsOur research focuses on understanding how immune responses initiate and accelerate synaptic and neuronal injury in age-related neurodegeneration, including models of Alzheimer's disease and Parkinson's disease. We also focus on the role of immune responses in aggravating brain injury in models of stroke. Our goal is the identification of critical immune pathways that function in neurologic disorders and that can be targeted to elicit disease modifying effects.